MediPal Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MAHLY research report →
About the company
Medipal Holdings Corporation, a Tokyo-based Japanese company founded in 1898, primarily operates as a wholesaler of prescription pharmaceuticals throughout Japan. Beyond its core drug distribution, the company also sources and supplies a comprehensive range of healthcare-related products, including medical equipment, materials, and clinical diagnostic reagents, used from the earliest pre-symptomatic stages through treatment. Its services extend to offering post-marketing surveillance (PMS) to pharmaceutical manufacturers and investing in the development of orphan drugs.
- CEO
- Shuichi Watanabe
- IPO
- 2009
- Employees
- 13,075
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $3.33B
- P/E
- 12.80
- P/S
- 0.14
- P/B
- 0.82
- EV/EBITDA
- 2.29
- Div Yield
- 2.49%
- Gross Margin
- 6.48%
- Op Margin
- 1.39%
- Net Margin
- 1.11%
- ROE
- 6.72%
- ROIC
- 4.04%
- Revenue
- $4.05T · 10.25%
- Net Income
- $45.10B · 11.97%
- EPS
- $218.90 · 13.31%
- Op Income
- $56.39B
- FCF YoY
- -12.02%
- 52W High
- $20.35
- 52W Low
- $14.60
- 50D MA
- $18.14
- 200D MA
- $17.99
- Beta
- -0.04
- Avg Volume
- 69
Get TickerSpark's AI analysis on MAHLY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MAHLY coverage
Recent articles, reports, and earnings notes.
No research on MAHLY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MAHLY report →Similar companies
Peers in the same neighborhood.